SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-009159
Filing Date
2023-03-20
Accepted
2023-03-20 19:52:53
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9246
  Complete submission text file 0000899243-23-009159.txt   10664
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5370 RUETTE DE MER SAN DIEGO CA 92130
Business Address
Ji Henry (Reporting) CIK: 0001470981 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 23747566